Pharma-Bio Serv FY2024 rev $9.5M (-$7.5M YoY), net loss $0.8M; declares $0.075 special dividend

Pharma-Bio Serv, Inc.

Revenue for year ended Oct 31, 2024 approximately $9.5M, a decrease of $7.5M from prior year.
Net loss of approximately $0.8M compared to net income of $1.3M in the prior year.
Board approved a Special Dividend of $0.075 per share payable on or about March 20, 2025.
CEO cited challenging industry conditions in 2024; focused on higher-value services and new technologies.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.